These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 25735064)

  • 1. A case of gastric cancer following living donor liver transplantation.
    Takehara H; Tanabe K; Fujikuni N; Tahara H; Ide K; Tanaka Y; Yasui W; Ohdan H
    Hiroshima J Med Sci; 2014 Sep; 63(1-3):23-6. PubMed ID: 25735064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experience of gastric cancer in a patient who had received a living-donor liver transplantation.
    Nagata Y; Eguchi S; Takatsuki M; Enjoji A; Ichikawa T; Hayashi T; Kanematsu T
    Gastric Cancer; 2007; 10(3):187-90. PubMed ID: 17922098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the outcomes of patients who underwent deceased-donor or living-donor liver transplantation after successful downstaging therapy.
    Lei J; Yan L; Wang W
    Eur J Gastroenterol Hepatol; 2013 Nov; 25(11):1340-6. PubMed ID: 23652915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of gastric cancer after living donor liver transplantation.
    Shimizu T; Hayashi M; Inoue Y; Komeda K; Asakuma M; Hirokawa F; Miyamoto Y; Tanigawa N; Uchiyama K
    Ann Transplant; 2012; 17(2):122-6. PubMed ID: 22743730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. De novo hepatocellular carcinoma in a liver graft with sustained hepatitis C virus clearance after living donor liver transplantation.
    Morita K; Taketomi A; Soejima Y; Ikegami T; Fukuhara T; Iguchi T; Nagata S; Sugimachi K; Gion T; Shirabe K; Maehara Y
    Liver Transpl; 2009 Nov; 15(11):1412-6. PubMed ID: 19877253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Living donor liver transplantation followed by total gastrectomy--a two-stage planed operative strategy for early gastric cancer concomitant with decompensated liver cirrhosis.
    Nishimura S; Saeki H; Ikegami T; Ando K; Yamashita Y; Oki E; Yoshizumi T; Morita M; Shirabe K; Maehara Y
    Anticancer Res; 2014 Aug; 34(8):4307-10. PubMed ID: 25075063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors affecting survival at recurrence of hepatocellular carcinoma after living-donor liver transplantation: with special reference to neutrophil/lymphocyte ratio.
    Harimoto N; Shirabe K; Nakagawara H; Toshima T; Yamashita Y; Ikegami T; Yoshizumi T; Soejima Y; Ikeda T; Maehara Y
    Transplantation; 2013 Dec; 96(11):1008-12. PubMed ID: 24113512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Living-donor liver transplantation associated with higher incidence of hepatocellular carcinoma recurrence than deceased-donor liver transplantation.
    Park MS; Lee KW; Suh SW; You T; Choi Y; Kim H; Hong G; Yi NJ; Kwon CH; Joh JW; Lee SK; Suh KS
    Transplantation; 2014 Jan; 97(1):71-7. PubMed ID: 24056623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salvage living donor liver transplantation after prior liver resection for hepatocellular carcinoma.
    Hwang S; Lee SG; Moon DB; Ahn CS; Kim KH; Lee YJ; Ha TY; Song GW
    Liver Transpl; 2007 May; 13(5):741-6. PubMed ID: 17457860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Living donor liver transplantation versus deceased donor liver transplantation for hepatocellular carcinoma: comparable survival and recurrence.
    Sandhu L; Sandroussi C; Guba M; Selzner M; Ghanekar A; Cattral MS; McGilvray ID; Levy G; Greig PD; Renner EL; Grant DR
    Liver Transpl; 2012 Mar; 18(3):315-22. PubMed ID: 22140013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrochimerism of donor type CD56+ CD3+ T cells in donor specific transfusion via portal vein following living related donor liver transplantation.
    Sato Y; Ichida T; Watanabe H; Yamamoto S; Abo T; Hatakeyama K
    Hepatogastroenterology; 2003; 50(54):2161-5. PubMed ID: 14696487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporary cardiac pacing for fatal arrhythmia in living-donor liver transplantation: three case reports.
    Kobayashi T; Sato Y; Yamamoto S; Oya H; Takeishi T; Kokai H; Hatakeyama K
    Transplant Proc; 2008 Oct; 40(8):2818-20. PubMed ID: 18929869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Living donor versus deceased donor liver transplantation for early irresectable hepatocellular carcinoma.
    Lo CM; Fan ST; Liu CL; Chan SC; Ng IO; Wong J
    Br J Surg; 2007 Jan; 94(1):78-86. PubMed ID: 17016793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Living donor liver transplantation for hepatocellular carcinoma: long-term results compared with deceased donor liver transplantation.
    Di Sandro S; Slim AO; Giacomoni A; Lauterio A; Mangoni I; Aseni P; Pirotta V; Aldumour A; Mihaylov P; De Carlis L
    Transplant Proc; 2009 May; 41(4):1283-5. PubMed ID: 19460539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Living Donor Liver Transplantation in an Elderly Recipient with Preserved Performance Status : A Case Report.
    Shimagaki T; Yoshizumi T; Kimura K; Motomura T; Nagatsu A; Okabe H; Itoh S; Harada N; Harimoto N; Ikegami T; Uchiyama H; Soejima Y; Maehara Y
    Fukuoka Igaku Zasshi; 2016 Jun; 107(6):115-20. PubMed ID: 29210543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Living donor liver transplantation for hepatocellular carcinoma: a single-center preliminary report.
    Malagó M; Sotiropoulos GC; Nadalin S; Valentin-Gamazo C; Paul A; Lang H; Radtke A; Saner F; Molmenti E; Beckebaum S; Gerken G; Frilling A; Broelsch CE
    Liver Transpl; 2006 Jun; 12(6):934-40. PubMed ID: 16528715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experience of the transplant team is an important factor for posttransplant survival in patients with hepatocellular carcinoma undergoing living-donor liver transplantation.
    Majeed TA; Wai CT; Rajekar H; Lee KH; Wong SY; Leong SO; Singh R; Tay KH; Chen J; Tan KC
    Transplant Proc; 2008 Oct; 40(8):2507-9. PubMed ID: 18929781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Living-donor liver transplantation for hepatocellular carcinoma.
    Kaihara S; Kiuchi T; Ueda M; Oike F; Fujimoto Y; Ogawa K; Kozaki K; Tanaka K
    Transplantation; 2003 Feb; 75(3 Suppl):S37-40. PubMed ID: 12589138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcomes of living donor liver transplantation for hepatitis C virus (HCV)-positive patients.
    Takada Y; Haga H; Ito T; Nabeshima M; Ogawa K; Kasahara M; Oike F; Ueda M; Egawa H; Tanaka K
    Transplantation; 2006 Feb; 81(3):350-4. PubMed ID: 16477219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective study on the outcome of patients with hepatocellular carcinoma registered for living donor liver transplantation: how long can they wait?
    Mizuno S; Yokoi H; Shiraki K; Usui M; Sakurai H; Tabata M; Sugimoto K; Takei Y; Yamakado K; Takeda K; Uemoto S; Isaji S
    Transplantation; 2010 Mar; 89(6):650-4. PubMed ID: 20048691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.